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Abstract
Pemphigus foliaceus is an organ-specific autoimmune disease characterized by autoantibodies against the extra-
cellular region of desmoglein 1, a protein that mediates intercellular adhesion in desmosomes. Cytotoxic T-
lymphocyte-associated protein 4 (CTLA-4) is a key negative regulator of the T cell immune response, playing an im-
portant role in T cell homeostasis and maintenance of peripheral tolerance. Polymorphisms in the CTLA4 gene have
been associated with autoimmune diseases and the functional CT60 single nucleotide polymorphism (rs3087243,
also named 6230G > A) has been proposed to be a casual variant in several of these diseases. The aim of this study
was to ascertain whether this polymorphism is associated with inter-individual variation in susceptibility to pem-
phigus foliaceus. The population sample in this case-control association study comprised 248 patient and 367 con-
trols. We did not found a significant association of pemphigus foliaceus with the CT60 variants. We conclude that the
CTLA4 CT60 polymorphism is not an important factor for pemphigus foliaceus pathogenesis in the population ana-
lyzed.
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The 2q33 chromosome region harbors genes that en-
code costimulatory molecules, such as the cytotoxic
T-lymphocyte-associated protein 4 (CTLA4), the cluster of
differentiation molecule 28 (CD28) and the inducible co-
stimulatorymolecule(ICOS),allofwhichplaycrucialroles
in T cell activation and regulation (Ling et al., 2001).
CTLA-4 is a key molecule expressed by activated T
cells that transduces an inhibitory signal after binding to
CD80 or CD86 on antigen-presenting cells. CTLA-4 ap-
pears to inhibit immune responses by several mechanisms,
besides being a critical mediator in peripheral tolerance.
Based on its crucial role in immunological homeostasis,
CTLA4hasbecomeoneofthemaingenesofresearchinter-
est for association studies and has been considered as a tar-
get for immunotherapy (Scalapino and Daikh, 2008).
Polymorphisms in CTLA4 are associated with a very wide
range of inflammatory and autoimmune diseases (for a re-
view,seeKristiansenetal.,2000;Goughetal.,2005).Sev-
eral SNPs have been identified in the 2q33 region compris-
ing CD28, CTLA4 and ICOS genes (Ueda et al., 2003). The
authors found associations between polymorphisms in the
segmentthatincludesthe3’regionofthe CTLA4genewith
Graves disease, hypothyroidism and autoimmune type I di-
abetes. Among these polymorphisms, the SNP CT60G>A
(rs3087243, also denominated 6230G>A), was the most-
associated marker. The CT60*G allele was correlated with
higher disease susceptibility and lower mRNA levels of the
soluble alternative splice form of CTLA-4 (sCTLA-4). Re-
cent studies also suggested that polymorphisms in the
CTLA4 gene may influence the development of autoim-
munediseases.Palaciosetal.(2008)concludedthatregula-
tory SNPs in the CTLA4 gene exert a strong influence on
expression levels of both known CTLA-4 isoforms. More-
over, association between CT60 polymorphism and varia-
tion in the frequency of regulatory T cells has been re-
ported. Individuals homozygous for allele CT60*A showed
an increase from 30-40% in the frequency of regulatory T
cells. Although the basic mechanism connecting the
CT60*AallelewithanincreaseinregulatoryTcellshasnot
yet been established, these differences reveal a relationship
between CT60 polymorphism and variation in adaptive im-
mune responses (Atabani et al., 2005).
Endemic pemphigus foliaceus (PF), also known as
fogo selvagem (meaning ‘wild fire’), is an organ-specific
autoimmune disease characterized by autoantibodies
against desmoglein 1 protein and by loss of adhesion be-
tween keratinocytes, leading to intraepithelial blisters of
theskin(Warrenetal.,2000).Severalcandidategeneshave
been analyzed for associations with PF. The HLA class II
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Short Communicationgenes(Pavonietal.,2003)andtheCD40Lgene(Malheiros
and Petzl-Erler, 2009) showed the strongest associations.
In addition, interactions between some of the genes ana-
lyzed have been reported (Martel et al., 2002; Malheiros
and Petzl-Erler, 2009). Two SNPs in the CTLA4 gene,
-318C>T and 49A>G, had been previously analyzed, al-
though no association with PF disease susceptibility was
observed (Pavoni et al., 2006).
Based on the reported associations between suscepti-
bility to autoimmune diseases and CTLA4 polymorphisms,
especially the CT60 SNP, the aim of this study was to ex-
tend analysis of this candidate gene to evaluate whether the
CT60 polymorphism is a factor contributing to differential
genetic susceptibility to pemphigus foliaceus in the Brazil-
ian population.
We analyzed 248 patients and 367 controls without
historyofthedisease,allunrelatedtoeachother.Diagnosis
was according to clinical and histological criteria. Patients
and controls were contacted at Hospital Adventista do Pên-
figo,CampoGrande,MatoGrossodoSulState,Brazil.Ad-
ditional controls were contacted in Curitiba, Paraná State,
Brazil. Patients and controls were matched for ancestry.
Seventy percent of the individuals were of predominantly
European and 30% of predominantly African ancestry. The
male:female ratio was close to one, viz. 47% of the patients
and 45% of the controls were males. According to age of
diseaseonset,distributionwasasfollows:from0to9years,
4.2%; 10-14 years, 8.3%; 15-19, 13.1%; 20-24, 11.3%;
25-29, 9.5%; 30-34, 9.5%; 35-39, 12.9%; 40-44, 8.3%;
45-49, 10.1%; 50-59, 5.4%; 60-69, 4.2%; 70-84, 3.6%.
Writteninformedconsentwasobtainedfromallthepartici-
pants.ThestudyreceivedapprovalbytheHumanResearch
Ethics Committee, in accordance with Brazilian Federal
Laws.
Genotyping was performed by polymerase chain re-
action amplification followed by restriction fragment
length polymorphism analysis (PCR-RFLP). The primers
and PCR conditions were the same as those described by
Teutsch et al. (2004). Allelic, genotypic and allele carrier
frequencies(i.e.,thefrequencyofindividualshavingtheal-
lele in either homozygosity or heterozygosity) were esti-
mated by direct counting. Hardy-Weinberg equilibrium
was assessed with the Guo and Thompson (1992) method
implemented in the ARLEQUIN version 3.11 software
package(Excoffieretal.,2005).Comparisonsbetweenfre-
quenciesinthepatientandcontrolpopulationsampleswere
performed by analysis of contingency tables by the chi-
square test of independence. The strength of the associa-
tions was estimated by the odds ratio (OR), using Woolf’s
method. The p value of 0.05 was adopted as the signifi-
cance limit for all statistical tests. The genotype taken as
reference was CTLA4 CT60 G/G. Therefore, by definition,
the OR for this genotype equals 1 and the OR for A/G and
A/AapproachtheriskofthesegenotypesrelativetotheG/G
genotype.
Allelic, genotypic and allele carrier frequencies are
presented in Table 1. Genotype frequencies were in Har-
dy-Weinberg equilibrium (p = 0.115 and p = 0.829 in pa-
tient and control population samples, respectively). No
significant association between PF disease status and CT60
variants was detected.
Associations previously described between suscepti-
bility to some autoimmune diseases and CT60 polymor-
phismhavebeeninterpretedconsideringthepossibleeffect
ofthisSNPinthealterationoftheratioofCTLA-4splicing
isoforms,andthatelevatedlevelsofsCTLA-4havealready
beendetectedincertainautoimmunedisorders(Uedaetal.,
2003;Saverinoetal.,2007;Kawasakietal.,2008).Inaddi-
tion, the hypothesis has been raised that sCTLA-4 is in-
volved in control of T cell activation, its levels being
regulated by genetic variation in chromosome region 2q33
(Kaartinen et al., 2007). Although several diseases have
been associated with CT60 polymorphism (see above), fur-
ther studies of the same and other autoimmune diseases in
various populations have failed to detect associations, thus
concurring with our results (for example, Chang et al.,
2007; Tsukahara et al., 2008). One reason for these con-
flicting results may be differences in allelic and haplotypic
frequencies of this marker among populations. Another ex-
planation is that the set of genes contributing to the estab-
lishment of different autoimmune diseases is not the same,
and that the CTLA4 gene is important in some diseases but
not in others.
In this study, we expanded our previous findings re-
garding variation in the CTLA4 gene by analyzing CT60
polymorphism. Our results lead to the conclusion that ge-
netic variation in CTLA4 does not play an important role in
PF susceptibility and that the effect of variations in this
gene differs among autoimmune diseases. We do not ex-
clude the involvement of the CTLA-4 molecule in PF
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Table 1 - Genotypic, allele carrier, and allelic frequencies for the CT60
SNP in patients and controls.
Frequency (%)
Patients
(n = 248)
Controls
(n = 367)
OR
1 95% CI
2 p
3
Genotypes
G/G 37.9 33.2 1
A/G 43.1 49.6 0.76 0.53-1.09 0.14
A/A 19.0 17.2 1.03 0.65-1.64 0.89
Allele carriers
G+ 81.0 82.8 0.89 0.58-1.35 0.57
A+ 62.1 66.8 0.82 0.58-1.14 0.23
Alleles
G 59.5 58.0 1.06 0.84-1.34 0.62
A 40.5 42.0 0.94 0.75-1.19 0.62
1Odds ratio;
2Confidence interval;
3Probability values.pathogenesis, but show that CT60 genotypes have no sig-
nificantimpactonpemphigusfoliaceusdiseasesusceptibil-
ity.
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